Clinical Trial Update: Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot) [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial studied aromatase inhibitors and weight loss in severely obese hypogonadal male veterans; results were completed with posted results in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Obesity

Snippet

Sponsor: Baylor College of Medicine | Conditions: Hypogonadism, Severe Obesity | Phase 4 | Status: COMPLETED | Results posted: 2020-01-30